AIT Therapeutics, Inc.'s board has approved to change the company's fiscal year-end to March 31 from Dec. 31.
The change becomes effective as of March 31, the New York-based medical device maker said in an SEC filing.
AIT plans to file a Form 10-KT covering the three-month transition period from Jan. 1 to March 31 on or before Aug. 8, it said in the filing.
